“…PMCs were grown in M199 medium (Gibco, 11150-059) supplemented with 10% FBS, 1% penicillin and streptomycin, bFGF (Peprotech, Rocky Hill, NJ, USA), EGF (Peprotech), and insulin (Sigma, St. Louis, MO, USA) at 37°C in a humidified 5% CO 2 atmosphere. PHCs were cultured in DMEM/F12 supplemented with 5% FBS, 1% penicillin and streptomycin, and ITS (insulin, transferrin, and selenous acid) + Premix (BD Biosciences, San Jose, CA, USA catalog: 354352) as previously described [25,26,27,28,29] at 37°C in a humidified 5% CO 2 atmosphere. Chondrogenic ATDC5 cells, PHCs, and PMCs were treated with recombinant IL-1β (Peprotech, 200-01B) using various doses and times [30,31,32].…”